Study of Women's Health Across the Nation (SWAN) V: Coordinating Center
全国妇女健康研究 (SWAN) V:协调中心
基本信息
- 批准号:9108798
- 负责人:
- 金额:$ 246.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-09-30 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptedAdrenal hormone preparationAgeAgingAncillary StudyArchivesAreaBiologicalBiological AssayBody CompositionBody SizeCLIA certifiedCalendarCardiovascular systemCharacteristicsChinese PeopleChronologyClinic VisitsClinicalCohort StudiesCollaborationsCommunitiesComplexComputer softwareCreativenessDataData CollectionData SetDatabasesDevelopmentDiseaseDocumentationEnrollmentEnsureEnvironmentEpidemiologic StudiesEpidemiologyEthnic OriginFosteringFoundationsGenitourinary systemHealthHemostatic functionHispanicsHormonal ChangeHormonesHourHousingInflammationInstitutionInvestigationJapanese PopulationK-Series Research Career ProgramsKnowledgeLaboratoriesLeadLeadershipLife ExperienceLinkLongitudinal StudiesManuscriptsMeasuresMenopauseMental HealthMethodologyMethodsMonitorMovementNatural HistoryNatureOutcomeOvarianParticipantPatternPerimenopausePersonal SatisfactionPhysical FunctionPhysiologicalPositioning AttributePostmenopausePremenopausePreparationPreventionPrevention programProductivityProtocols documentationPublic Health SchoolsPublicationsQuality ControlRaceReadingReportingReproductive HealthResearch InfrastructureResearch PersonnelResourcesRisk FactorsRoleSecureSex FunctioningSexual HealthSiteSleepSocioeconomic StatusSourceSpecimenStatistical MethodsStrategic PlanningSupport SystemSymptomsSystemTechniquesTechnologyTimeUniversitiesVaginaVasomotorVisitWomanWomen&aposs HealthWritingactigraphyadipokinesage relatedbaseboneclinical practiceclinical research siteclinically relevantcognitive functioncohortcomputerizeddata managementdesigndisorder riskexperiencefollow-upimprovedinnovationinsightlongitudinal analysismeetingsmiddle agepsychologicpsychosocialpublic health relevanceracial and ethnicracial differencerepositoryreproductive senescenceresponseskeletalsocioeconomicsstatistical centertreatment program
项目摘要
DESCRIPTION (provided by applicant): This is the amended competing renewal application of the Study of Women's Health Across the Nation (SWAN), a 7-site longitudinal cohort study initiated in 1994 in response to RFA AG-94-002. SWAN was mandated "to characterize the chronology of the biological and psychosocial antecedents and sequelae of the menopausal transition (MT) and the effect of this transition on subsequent health and risk factors for age- related disease", and to extend this information from White women to "...the range of peri-menopausal experiences in women of other racial/ethnic background(s)." A total of 3302 Black, Chinese, Japanese, Hispanic and White women were enrolled, with 78% completing up to 13 visits spanning the premenopause to early post-menopause (PM). Thus far, SWAN has described the natural history of the MT -- its timing, patterns of hormonal changes, and symptoms and factors related to them - and their relation to disease risk indicators. During SWAN V, we will extend observations through the late PM, a necessary step to assess the impact of the MT on age-related diseases. Our specific aims are to: 1) complete the characterization of the natural history of reproductive aging through the late PM; 2) evaluate the impact of reproductive aging through the late PM on health outcomes clinically relevant to women in their 60s and 70s, including: cognitive and physical function, psychological well-being, sleep, bone and cardiometabolic health, urogenital symptoms, sexual function and vaginal health; and 3) identify potential underlying mechanisms linking reproductive aging and health by assessing the relation of inflammation, hemostasis and adipokines to the occurrence and progression of biological, functional and clinical outcomes and delineating the interrelationships of body size and composition, race/ethnicity and socioeconomic status with these outcomes. The SWAN V Core protocol will be completed at 7 study sites, with bone and cardiovascular studies at 4 sites and actigraphy studies in a subset of women at all sites. Longitudinal specimens from the SWAN Repository will enable characterization of skeletal markers, adrenal hormones, hemostasis, inflammation, and adipokines across the MT into PM. The Coordinating Center will provide the necessary organizational infrastructure, statistical resources, and timely dissemination of high quality SWAN data. The CLIA-certified Central Laboratory will perform or coordinate with other laboratories to provide accurate, high volume assays, adopting new methods as needed to provide state- of-the-art data. SWAN is uniquely positioned to fill important scientific gaps in understanding of the impact of the MT on women's health in their 60s and 70s and to facilitate the application of new knowledge to clinical practice. With 1.5 decades of both calendar time and "menopause time", SWAN V can disaggregate the contributions of aging and the MT to women's health, address difficult and critical questions about the temporal nature of MT-disease associations, assess differences by race/ethnicity, and provide insights into modifiable factors relevant to the design of innovative prevention and treatment programs for aging women.
描述(由申请人提供):这是对全国妇女健康研究(SWAN)的竞争性更新的应用,这是一项针对RFA AG-94-002的7个地点纵向队列研究。斯旺被授权“表征了绝经过渡(MT)的生物学和心理社会前因和后遗症的年代学,以及这种过渡对随后的与年龄相关疾病的健康和风险因素的影响”,并将这些信息从白人女性扩展到………………在其他种族/其他种族/其他种族背景(S)的范围”。总共招募了3302名黑色,中国,日本,西班牙裔和白人妇女,其中78%的人完成了13次访问,涉及前期早期到少年后(PM)。到目前为止,天鹅已经描述了MT的自然历史 - 其时间,激素变化的模式以及与之相关的症状和因素 - 以及它们与疾病风险指标的关系。在天鹅v期间,我们将通过PM晚期进行观察,这是评估MT对年龄相关疾病的影响的必要步骤。我们的具体目的是:1)完成PM晚期生殖老化的自然历史的表征; 2)评估PM晚期生殖老化对与60年代和70年代女性有关的健康结果的影响,包括:认知和身体机能,心理健康,睡眠,骨骼和心脏代谢健康,泌尿生殖器症状,性功能和阴道健康; 3)通过评估炎症,止血和脂肪因子与生物学,功能和临床结局的发生和进展,并划定身体大小,种族/种族/族裔和社会经济状况的相互关系来确定与生殖老化和健康联系的潜在潜在机制。天鹅V核心方案将在7个研究地点完成,在所有地点的一部分女性中,在4个地点进行骨和心血管研究。天鹅储存库的纵向标本将使骨骼标记,肾上腺激素,止血,炎症和脂肪因子跨MT横跨PM进行表征。协调中心将提供必要的组织基础设施,统计资源以及及时传播高质量的天鹅数据。经过CLIA认证的中央实验室将与其他实验室进行或协调,以提供准确,大量的测定法,并根据需要采用新方法来提供状态数据。天鹅在理解60年代和70年代妇女对妇女健康的影响方面的重要科学空白方面处于独特状态,并促进将新知识应用于临床实践。 Swan V有1.5年的日历时间和“更年期时间”,可以分解衰老和MT对妇女健康的贡献,解决有关MT-Disease关联的时间性质的困难和关键问题,评估种族/民族的差异,并将与可修改的因素相关,使其与针对预防预防和治疗女性设计的可修改因素相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Mori Brooks其他文献
ORBITA revisited: what it really means and what it does not?
重新审视 ORBITA:它的真正含义是什么,不是什么?
- DOI:
10.1093/eurheartj/ehx796 - 发表时间:
2018 - 期刊:
- 影响因子:39.3
- 作者:
B. Chaitman;Maria Mori Brooks;K. Fox;T. Lüscher - 通讯作者:
T. Lüscher
CULTURING BLASTOCYSTS TO DAY 7 OF DEVELOPMENT YIELDS DECREASED ODDS OF LIVE BIRTH FOLLOWING EUPLOID FROZEN EMBRYO TRANSFER
- DOI:
10.1016/j.fertnstert.2024.07.886 - 发表时间:
2024-10-01 - 期刊:
- 影响因子:
- 作者:
Belita Opene;Nicole M. Fischer;Alexandra A. Szczupak;Roy G. Handelsman;Julie M. Rios;Maria Mori Brooks;Jiaxuan Duan;Bernadette Paternoster;G. David Ball;Pamela B. Parker;Melissa Lombardozzi - 通讯作者:
Melissa Lombardozzi
Maria Mori Brooks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Mori Brooks', 18)}}的其他基金
The Study of Women's Health Across the Nation (SWAN): The Impact of Midlife and the Menopause Transition on Health and Functioning in Early Old Age
全国妇女健康研究 (SWAN):中年和更年期过渡对早年健康和功能的影响
- 批准号:
10911525 - 财政年份:2020
- 资助金额:
$ 246.22万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10402934 - 财政年份:2019
- 资助金额:
$ 246.22万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10163253 - 财政年份:2019
- 资助金额:
$ 246.22万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
9926916 - 财政年份:2019
- 资助金额:
$ 246.22万 - 项目类别:
2/2 Sickle Cell Disease and CardiovAscular Risk - Red cell Exchange Trial (SCD-CARRE Trial)
2/2 镰状细胞病和心血管风险 - 红细胞交换试验(SCD-CARRE 试验)
- 批准号:
10642928 - 财政年份:2019
- 资助金额:
$ 246.22万 - 项目类别:
Myocardial Ischemia and Transfusion (MINT) - DCC
心肌缺血和输血 (MINT) - DCC
- 批准号:
10290738 - 财政年份:2016
- 资助金额:
$ 246.22万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Development and translation of a novel radioligand to measure pathological changes in glucocorticoid receptor expression in the brain
开发和翻译一种新型放射性配体,用于测量大脑中糖皮质激素受体表达的病理变化
- 批准号:
9427881 - 财政年份:2017
- 资助金额:
$ 246.22万 - 项目类别:
Washington Obstetric-Fetal Pharmacology Research Unit
华盛顿产胎儿药理学研究单位
- 批准号:
7695403 - 财政年份:2004
- 资助金额:
$ 246.22万 - 项目类别:
Study of Women's Health Across the Nation (SWAN) V: Chicago site
全国妇女健康研究 (SWAN) V:芝加哥站点
- 批准号:
8757072 - 财政年份:1994
- 资助金额:
$ 246.22万 - 项目类别:
Study of Women's Health Across the Nation (SWAN): New Jersey
全国妇女健康研究 (SWAN):新泽西州
- 批准号:
9132656 - 财政年份:1994
- 资助金额:
$ 246.22万 - 项目类别:
STUDY OF WOMEN'S HEALTH ACROSS THE NATION (SWAN) V: UC DAVIS/KAISER
全国女性健康研究 (SWAN) V:加州大学戴维斯分校/凯撒大学
- 批准号:
8762221 - 财政年份:1994
- 资助金额:
$ 246.22万 - 项目类别: